Lora Talley Watts
Overview
Explore the profile of Lora Talley Watts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
812
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang S, Shen Q, Watts L, Long J, OBoyle M, Nguyen T, et al.
Neurotrauma Rep
. 2021 Dec;
2(1):526-540.
PMID: 34901946
Although resting-state functional magnetic resonance imaging (rsfMRI) has the potential to offer insights into changes in functional connectivity networks after traumatic brain injury (TBI), there are few studies that examine...
2.
Garling R, Watts L, Sprague S, Digicaylioglu M
Neural Regen Res
. 2018 Apr;
13(3):434-439.
PMID: 29623927
The mechanistic target of rapamycin (mTOR) is an intracellular protein kinase that functions as an energy and nutrient sensor in the cellular microenvironment of neurons. Modulation of mTOR is vital...
3.
Vekaria H, Watts L, Lin A, Sullivan P
Neurochem Int
. 2017 Apr;
109:117-125.
PMID: 28396091
Complex, multi-factorial secondary injury cascades are initiated following traumatic brain injury, which makes this a difficult disease to treat. The secondary injury cascades following the primary mechanical tissue damage, are...
4.
5.
Watts L, Zheng W, Garling R, Frohlich V, Lechleiter J
J Vis Exp
. 2015 Jul;
(100):e52794.
PMID: 26131664
In vivo imaging techniques have increased in utilization due to recent advances in imaging dyes and optical technologies, allowing for the ability to image cellular events in an intact animal....
6.
Jiang Z, Watts L, Huang S, Shen Q, Rodriguez P, Chen C, et al.
PLoS One
. 2015 Jun;
10(6):e0131929.
PMID: 26121129
Methylene blue (MB) USP, which has energy-enhancing and antioxidant properties, is currently used to treat methemoglobinemia and cyanide poisoning in humans. We recently showed that MB administration reduces infarct volume...
7.
Watts L, Long J, Boggs R, Manga H, Huang S, Shen Q, et al.
J Neurotrauma
. 2015 May;
33(2):194-202.
PMID: 25961471
Traumatic brain injury (TBI) remains a primary cause of death and disability in both civilian and military populations worldwide. There is a critical need for the development of neuroprotective agents...
8.
Watts L, Long J, Manga V, Huang S, Shen Q, Duong T
J Cereb Blood Flow Metab
. 2015 Feb;
35(7):1137-44.
PMID: 25690469
Traumatic brain injury (TBI) is a multifaceted injury and a leading cause of death in children, young adults, and increasingly in Veterans. However, there are no neuroprotective agents clinically available...
9.
Garling R, Watts L, Sprague S, Fletcher L, Jimenez D, Digicaylioglu M
Neural Regen Res
. 2015 Jan;
9(21):1891-6.
PMID: 25558238
There are currently no federally approved neuroprotective agents to treat traumatic brain injury. Progesterone, a hydrophobic steroid hormone, has been shown in recent studies to exhibit neuroprotective effects in controlled...
10.
Watts L, Shen Q, Deng S, Chemello J, Duong T
J Neurotrauma
. 2014 Dec;
32(13):1001-10.
PMID: 25531419
Calcium dysfunction is involved in secondary traumatic brain injury (TBI). Manganese-enhanced MRI (MEMRI), in which the manganese ion acts as a calcium analog and a MRI contrast agent, was used...